Lafayette, CA, United States of America

Yiu-Lan Fong

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Vaccines & Diagnostics, Gmbh. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yiu-Lan Fong. Retrieved from https://idiyas.com/inventor/yiu-lan-fong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yiu-Lan Fong: Innovator in Blood Testing Technology

Introduction

Yiu-Lan Fong is a notable inventor based in Lafayette, CA (US). He has made significant contributions to the field of medical diagnostics, particularly in blood testing technologies. His innovative work focuses on enhancing the efficiency and accuracy of blood screening methods.

Latest Patents

Yiu-Lan Fong holds a patent for a "Device and method for in-line blood testing using biochips." This device is designed for in-line blood screening and testing, utilizing biochips to perform nucleic acid amplification techniques and antibody/antigen assays. These methods are crucial for detecting target molecules and agents that indicate infectious or metabolic diseases. He has 1 patent to his name.

Career Highlights

Fong is currently employed at Novartis Vaccines & Diagnostics GmbH, where he continues to develop innovative solutions in the healthcare sector. His work at Novartis has positioned him as a key player in advancing diagnostic technologies.

Collaborations

Yiu-Lan Fong has collaborated with esteemed colleagues, including David Y Chien and Bruce Phelps. These partnerships have fostered a collaborative environment that enhances the development of cutting-edge medical technologies.

Conclusion

Yiu-Lan Fong's contributions to blood testing technology exemplify the impact of innovation in healthcare. His work not only advances diagnostic methods but also plays a vital role in improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…